Ali Nouraeinejad*

Ph.D. in Clinical Ophthalmology, Tehran University of Medical Sciences, Tehran, Iran

*Corresponding Author: Ali Nouraeinejad, Ph.D. in Clinical Ophthalmology, Tehran University of Medical Sciences, Tehran, Iran.

Received: May 22, 2021; Published: August 18, 2021

The prevalence of myopia and high myopia is rising worldwide at an alarming pace [1,2]. This is in an order or sequence of processes linked to significant increases in the risk of vision impairment from pathological conditions associated with high myopia, including retinal damage, cataract, and glaucoma [1,2].

Regrettably, the issue of vision impairment associated with myopia receives limited attention from a public health viewpoint in terms of assessment of prevalence, protective interventions, and possible treatment selections [1,2].

References

1. Nouraeinejad A. “Differential Diagnosis in Optometry and Ophthalmology”. Second Edition. Iran: Noruzi Publication (2017).
2. Nouraeinejad A. “A warning message from 2020 to 2050: More than half of the world population will be myopic by 2050”. [Lecture] Moorfields Eye Hospital. London (2020).
3. Holden BA., et al. “Global Prevalence of Myopia and High Myopia and Temporal Trends from 2000 through 2050”. Ophthalmology5 (2016): 1036-1042.

Citation

Citation: Ali Nouraeinejad. “The Myopia Impact".Acta Scientific Ophthalmology 4.9 (2021): 35-36.

Copyright

Copyright: © 2021 Ali Nouraeinejad. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.